In 2016, the Food and Drug Administration amended existing regulations to increase access to donated embryos for reproductive use. Current information regarding characteristics and outcomes of embryo donation cycles could benefit patients and providers during counseling and decision making. To examine trends in utilization of embryo donation, pregnancy rates and live birth rates per transfer between 2004-2019; to describe recipients of donated embryos and outcomes of frozen donated embryo transfer cycles during the most recent time period: 2016-2019 STUDY DESIGN: We conducted a retrospective population-based cohort study of frozen donated embryo transfer cycles in United States fertility clinics reporting to the National Assisted Reproductive Technology Surveillance System during 2004-2019. Trends in the annual number and proportion of frozen donated embryo transfers, pregnancy rates and live birth rates from 2004-2019 were described. During 2016-2019, rate of cycle cancellation, pregnancy, miscarriage, live birth, singleton birth, and good perinatal outcome (delivery ≥37 weeks, birthweight ≥2500 grams) of frozen donated embryo transfers were also calculated. Transfer and pregnancy outcomes stratified by oocyte source age at the time of oocyte retrieval were also described. From 2004-2019, there were 21,060 frozen donated embryo transfers in the United States resulting in 8,457 live births. During this period, the annual number and proportion of frozen donated embryo transfers of all transfers increased, as did the pregnancy rate and live birth rate. Among all initiated cycles during 2016-2019, the cancellation rate was 8.2%. Among 8,773 transfers with known outcomes, 4,685 (53.4%) resulted in pregnancy and 3,820 (43.5%) in live birth. Among all pregnancies, 814 (17.4%) resulted in miscarriage. Among all live births, 3,223 (84.4%) delivered a singleton of which 2,474 (76.8%) had a good perinatal outcome. The clinical pregnancy rate and live birth rate per frozen donated embryo transfer decreased with increasing age of oocyte source. The outcomes of embryo donation cycles reported in this national cohort may aid patients and providers when considering use of donated embryos.